Medra Corporation (MDRA)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 29, 2025
Medra Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2001 | FY 2000 | FY 1999 | FY 1998 | FY 1997 |
---|---|---|---|---|---|---|
Period Ending | Jun '02 Jun 30, 2002 | Dec '01 Dec 31, 2001 | Dec '00 Dec 31, 2000 | Dec '99 Dec 31, 1999 | Dec '98 Dec 31, 1998 | Dec '97 Dec 31, 1997 |
Revenue | 1.13 | 1.14 | 0.96 | 0.54 | 0.21 | 0.09 |
Revenue Growth (YoY) | 39.95% | 18.87% | 77.02% | 161.68% | 131.28% | - |
Cost of Revenue | 1.45 | 1.04 | 0.73 | 0.33 | 0.07 | - |
Gross Profit | -0.32 | 0.1 | 0.23 | 0.21 | 0.14 | 0.09 |
Selling, General & Admin | 0.82 | 2.77 | 4.45 | 2.87 | 2.88 | 0.21 |
Research & Development | 1.8 | 2.48 | 1.78 | 0.84 | 1.81 | 0.06 |
Operating Expenses | 7.56 | 10.01 | 7.74 | 3.78 | 4.72 | 0.28 |
Operating Income | -7.88 | -9.91 | -7.51 | -3.57 | -4.58 | -0.19 |
Interest Expense | -0.05 | -0.05 | -0.05 | -0 | - | - |
Interest & Investment Income | 0.03 | 0.03 | 0.13 | - | - | 0 |
Earnings From Equity Investments | -0.02 | -0.02 | -0.01 | -0.02 | - | - |
Other Non Operating Income (Expenses) | 0.06 | 0.07 | - | - | 0 | - |
EBT Excluding Unusual Items | -7.86 | -9.88 | -7.44 | -3.59 | -4.58 | -0.19 |
Gain (Loss) on Sale of Investments | -0.01 | -0.01 | -0.19 | - | - | - |
Gain (Loss) on Sale of Assets | -0.05 | -0.05 | -0.03 | - | - | - |
Pretax Income | -7.92 | -9.94 | -7.65 | -3.59 | -4.58 | -0.19 |
Earnings From Continuing Operations | -7.92 | -9.94 | -7.65 | -3.59 | -4.58 | -0.19 |
Minority Interest in Earnings | 0.01 | 0.01 | - | - | - | - |
Net Income | -7.91 | -9.93 | -7.65 | -3.59 | -4.58 | -0.19 |
Net Income to Common | -7.91 | -9.93 | -7.65 | -3.59 | -4.58 | -0.19 |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | - | - |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | - | - |
Shares Change (YoY) | 31.72% | 32.46% | 64.81% | - | - | - |
EPS (Basic) | -225.91 | -313.29 | -319.87 | -247.09 | - | - |
EPS (Diluted) | -226.99 | -313.29 | -320.00 | -250.00 | - | - |
Free Cash Flow | -4.72 | -5.92 | -7.69 | -2.14 | -1.35 | 0.11 |
Free Cash Flow Per Share | -134.84 | -186.85 | -321.47 | -147.26 | - | - |
Gross Margin | -28.56% | 8.70% | 24.17% | 38.81% | 67.97% | 100.00% |
Operating Margin | -699.10% | -867.03% | -780.84% | -656.57% | -2207.26% | -207.31% |
Profit Margin | -701.93% | -868.76% | -796.01% | -660.43% | -2205.25% | -207.19% |
Free Cash Flow Margin | -418.95% | -518.15% | -800.00% | -393.61% | -649.08% | 119.94% |
EBITDA | -7.42 | -9.62 | -7.27 | -3.5 | -4.55 | -0.18 |
EBITDA Margin | - | - | - | - | - | -198.06% |
D&A For EBITDA | 0.46 | 0.29 | 0.23 | 0.07 | 0.03 | 0.01 |
EBIT | -7.88 | -9.91 | -7.51 | -3.57 | -4.58 | -0.19 |
EBIT Margin | - | - | - | - | - | -207.31% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.